Clinical trial

Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis

NCT00242164 · University of Michigan, Other · Completed

Key facts

NCT number NCT00242164
Title Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Official title Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Lead sponsor University of Michigan, Other
Collaborators Renal Research Institute
Status Completed
Phase Phase 2
Study type Interventional
Conditions Chronic Kidney Disease, Arrhythmia
Intervention type Drug
Interventions Dialysate Magnesium (Concentration)
Enrollment 25
Start date Nov 1, 2005
Primary completion Jun 1, 2006
Completion Nov 1, 2006
First posted Oct 19, 2005
Last update posted Dec 9, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies